Browse > Article
http://dx.doi.org/10.4046/trd.2010.69.3.163

Characteristics of Pulmonary Tuberculosis in Elderly People  

Shin, Ji-Young (Department of Internal Medicine, Chungnam National University College of Medicine)
Jung, Sun-Young (Department of Internal Medicine, Chungnam National University College of Medicine)
Lee, Jeong-Eun (Department of Internal Medicine, Chungnam National University College of Medicine)
Park, Ji-Won (Department of Internal Medicine, Chungnam National University College of Medicine)
Yoo, Su-Jin (Department of Internal Medicine, Chungnam National University College of Medicine)
Park, Hee-Sun (Department of Internal Medicine, Chungnam National University College of Medicine)
Kim, Ju-Ock (Department of Internal Medicine, Chungnam National University College of Medicine)
Kim, Sun-Young (Department of Internal Medicine, Chungnam National University College of Medicine)
Publication Information
Tuberculosis and Respiratory Diseases / v.69, no.3, 2010 , pp. 163-170 More about this Journal
Abstract
Background: Pulmonary tuberculosis remains a health concern in Korea despite major progress in the development of new strategies for diagnosing and treating tuberculosis. In particular, the diagnosis of newly developed pulmonary tuberculosis is on the rise in elderly persons. The aim of this study was to investigate the clinical, radiographic characteristics, and treatment outcomes of pulmonary tuberculosis in the elderly. Methods: The medical records of 113 young (<65 years old) and 112 elderly (${\geq}65$ years old) pulmonary tuberculosis patients diagnosed at Chungnam National University hospital between January 2007 and December 2008 were reviewed. Results: There was no difference in the prevalence of typical symptoms between the younger and the elderly group. Dypsnea was the only symptom that occurred more frequently in the elderly group (16.8% vs 5.5%, p=0.008). On radiological study, pneumonic infiltration type was more common in the elderly group (28.6% vs 16.8%, p=0.035). Sputum Acid fast bacilli smear positivity rate was similar between the 2 groups. Elderly patients with anti-tuberculosis medication had more frequent adverse drug reactions; however, there was no significant difference between the 2 groups in the number of patients required to stop medication due to an adverse drug reaction. There were more patients lost to follow-up in the elderly group (22/112, 19.6% vs 11/113, 9.7%, p=0.036). Conclusion: The majority of elderly patients did not complete the treatment, resulting in a poorer outcome. Therefore, we need to make an effort to support the continued screening of elderly patients by making this economically feasible.
Keywords
Tuberculosis, Pulmonary; Aged; Patient Compliance;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
Times Cited By SCOPUS : 0
연도 인용수 순위
1 Dutt AK, Stead WW. Tuberculosis in the elderly. Med Clin North Am 1993;77:1353-68.   DOI
2 Mackay AD, Cole RB. The problems of tuberculosis in the elderly. Q J Med 1984;53:497-510.
3 Park JS. Treatment of pulmonary tuberculosis in elderly. Korean J Intern Med 2008;75:141-8.
4 Schaberg T, Rebhan K, Lode H. Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis. Eur Respir J 1996;9:2026-30.   DOI   ScienceOn
5 Dye C, Watt CJ, Bleed DM, Hosseini SM, Raviglione MC. Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. JAMA 2005;293:2767-75.   DOI   ScienceOn
6 Yee D, Valiquette C, Pelletier M, Parisien I, Rocher I, Menzies D. Incidence of serious side effects from firstline antituberculosis drugs among patients treated for active tuberculosis. Am J Respir Crit Care Med 2003;167:1472-7.   DOI   ScienceOn
7 Teale C, Goldman JM, Pearson SB. The association of age with the presentation and outcome of tuberculosis: a five-year survey. Age Ageing 1993;22:289-93.   DOI   ScienceOn
8 Sharma SK, Balamurugan A, Saha PK, Pandey RM, Mehra NK. Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment. Am J Respir Crit Care Med 2002;166:916-9.   DOI   ScienceOn
9 Fernandez-Villar A, Sopena B, Fernandez-Villar J, Vazquez- Gallardo R, Ulloa F, Leiro V, et al. The influence of risk factors on the severity of anti-tuberculosis druginduced hepatotoxicity. Int J Tuberc Lung Dis 2004;8:1499-505.
10 van den Brande P, van Steenbergen W, Vervoort G, Demedts M. Aging and hepatotoxicity of isoniazid and rifampin in pulmonary tuberculosis. Am J Respir Crit Care Med 1995;152:1705-8.   DOI   ScienceOn
11 Umeki S. Age-related changes in the manifestations of tuberculosis. Implications for drug therapy. Drugs Aging 1991;1:440-57.   DOI   ScienceOn
12 Wynn GJ, Turkington PM, O'Driscoll BR. Anthracofibrosis, bronchial stenosis with overlying anthracotic mucosa: possibly a new occupational lung disorder--a series of seven cases from one UK hospital. Chest 2008;134:1069-73.   DOI   ScienceOn
13 Cohen AG. Atelectasis of the right middle lobe resulting from perforation of tuberculous lymph nodes into bronchi in adults. Ann Intern Med 1951;35:820-35.   DOI   ScienceOn
14 Chung MP, Lee KS, Han J, Kim H, Rhee CH, Han YC, et al. Bronchial stenosis due to anthracofibrosis. Chest 1998;113:344-50.   DOI   ScienceOn
15 Burrill J, Williams CJ, Bain G, Conder G, Hine AL, Misra RR. Tuberculosis: a radiologic review. Radiographics 2007;27:1255-73.   DOI   ScienceOn
16 Kashyap S, Mohapatra PR, Saini V. Endobronchial tuberculosis. Indian J Chest Dis Allied Sci 2003;45:247-56.
17 Kim HJ, Kim HS, Ma JE, Lee SJ, Ham HS, Cho YJ, et al. Clinical characteristics of endobronchial tuberculosis that develops in patients over 70 years of age. Tuberc Respir Dis 2007;63:412-6.   DOI   ScienceOn
18 Rao VK, Iademarco EP, Fraser VJ, Kollef MH. The impact of comorbidity on mortality following in-hospital diagnosis of tuberculosis. Chest 1998;114:1244-52.   DOI   ScienceOn
19 Patel YR, Mehta JB, Harvill L, Gateley K. Flexible bronchoscopy as a diagnostic tool in the evaluation of pulmonary tuberculosis in an elderly population. J Am Geriatr Soc 1993;41:629-32.   DOI
20 Khan MS, Dar O, Sismanidis C, Shah K, Godfrey-Faussett P. Improvement of tuberculosis case detection and reduction of discrepancies between men and women by simple sputum-submission instructions: a pragmatic randomised controlled trial. Lancet 2007;369:1955-60.   DOI   ScienceOn
21 Davies PD. The effects of poverty and ageing on the increase in tuberculosis. Monaldi Arch Chest Dis 1999;54:168-71.
22 Wang CS, Chen HC, Yang CJ, Wang WY, Chong IW, Hwang JJ, et al. The impact of age on the demographic, clinical, radiographic characteristics and treatment outcomes of pulmonary tuberculosis patients in Taiwan. Infection 2008;36:335-40.   DOI   ScienceOn
23 Leung CC, Yew WW, Chan CK, Chau CH, Tam CM, Lam CW, et al. Tuberculosis in older people: a retrospective and comparative study from Hong Kong. J Am Geriatr Soc 2002;50:1219-26.   DOI   ScienceOn
24 Katz I, Rosenthal T, Michaeli D. Undiagnosed tuberculosis in hospitalized patients. Chest 1985;87:770-4.   DOI   ScienceOn
25 Perez-Guzman C, Vargas MH, Torres-Cruz A, Villarreal- Velarde H. Does aging modify pulmonary tuberculosis? a meta-analytical review. Chest 1999;116:961-7.   DOI   ScienceOn
26 Ryu WJ. Treatment guidelines for tuberculosis. Seoul: The Korean Academy of Tuberculosis and Respiratory Disease; 2005.
27 Veen J, Raviglione M, Rieder HL, Migliori GB, Graf P, Grzemska M, et al. Standardized tuberculosis treatment outcome monitoring in Europe. Recommendations of a Working Group of the World Health Organization (WHO) and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform reporting by cohort analysis of treatment outcome in tuberculosis patients. Eur Respir J 1998;12:505-10.   DOI   ScienceOn